Skip to main content

Research Studies

Developmental Therapeutics Program Research Studies

Find research studies available to children cared for by the Developmental Therapeutics Program team.

Existing patients or family members
New patients, referrals and second opinions

Recruitment Status

Study categories

Specialty

Eligible age

Clinical trial phase

The LiFFT Study

This study involves taking a study drug called lurbinectedin. The overall goal of this study is to see if different doses of the study drug are safe and effective at treating children and young adults with recurrent or relapsed solid tumors, including Ewing sarcoma.

Phase: Phase I, Phase II

Actively recruiting: Yes

Category: Adults, Children

Conditions: Ewing sarcoma, Central Nervous System (CNS) Germ Cell Tumors

Jump back to top